DCM
NVO

Donaldson Capital Management’s Novo Nordisk NVO Stock Holding History

Donaldson Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$567K Sell
15,418
-376
-2% -$17.8K 0.02% 170
2025
Q4 		$804K Sell
15,794
-182
-1% -$9.31K 0.03% 153
2025
Q3 		$887K Sell
15,976
-93
-0.6% -$5.44K 0.03% 147
2025
Q2 		$1.11M Sell
16,069
-9,409
-37% -$640K 0.04% 132
2025
Q1 		$1.77M Sell
25,478
-9
-0% -$743 0.07% 109
2024
Q4 		$2.19M Sell
25,487
-5,474
-18% -$592K 0.08% 102
2024
Q3 		$3.69M Sell
30,961
-966
-3% -$129K 0.14% 72
2024
Q2 		$4.56M Sell
31,927
-702
-2% -$93K 0.19% 59
2024
Q1 		$4.19M Buy
32,629
+15
+0% +$1.79K 0.17% 65
2023
Q4 		$3.37M Sell
32,614
-2,825
-8% -$279K 0.15% 69
2023
Q3 		$3.22M Sell
35,439
-1,585
-4% -$140K 0.15% 69
2023
Q2 		$3M Sell
37,024
-2,626
-7% -$215K 0.14% 74
2023
Q1 		$3.15M Hold
39,650
– – 0.15% 75
2022
Q4 		$2.68M Buy
39,650
+448
+1% +$26.3K 0.13% 81
2022
Q3 		$1.95M Sell
39,202
-500
-1% -$26.8K 0.11% 81
2022
Q2 		$2.21M Sell
39,702
-42
-0.1% -$2.33K 0.11% 77
2022
Q1 		$2.21M Sell
39,744
-3,926
-9% -$201K 0.1% 81
2021
Q4 		$2.45M Hold
43,670
– – 0.11% 81
2021
Q3 		$2.1M Sell
43,670
-1,600
-4% -$77.4K 0.11% 82
2021
Q2 		$1.9M Sell
45,270
-3,700
-8% -$143K 0.1% 85
2021
Q1 		$1.65M Sell
48,970
-6,630
-12% -$236K 0.09% 90
2020
Q4 		$1.94M Buy
55,600
+5,000
+10% +$173K 0.11% 78
2020
Q3 		$1.76M Sell
50,600
-5,000
-9% -$167K 0.12% 77
2020
Q2 		$1.82M Hold
55,600
– – 0.13% 72
2020
Q1 		$1.67M Sell
55,600
-726
-1% -$21.6K 0.15% 71
2019
Q4 		$1.63M Sell
56,326
-882
-2% -$24.4K 0.11% 81
2019
Q3 		$1.48M Buy
57,208
+208
+0.4% +$5.26K 0.11% 85
2019
Q2 		$1.46M Sell
57,000
-712
-1% -$17.6K 0.12% 68
2019
Q1 		$1.51M Sell
57,712
-2,288
-4% -$56.2K 0.13% 65
2018
Q4 		$1.38M Sell
60,000
-15,176
-20% -$337K 0.14% 62
2018
Q3 		$1.77M Sell
75,176
-1,800
-2% -$43.9K 0.15% 67
2018
Q2 		$1.77M Sell
76,976
-93,908
-55% -$2.23M 0.17% 63
2018
Q1 		$4.21M Sell
170,884
-3,746
-2% -$98.3K 0.41% 40
2017
Q4 		$4.69M Buy
174,630
+5,604
+3% +$143K 0.46% 33
2017
Q3 		$4.07M Buy
169,026
+1,204
+0.7% +$27.2K 0.43% 35
2017
Q2 		$3.6M Buy
167,822
+22,978
+16% +$464K 0.41% 40
2017
Q1 		$2.48M Buy
144,844
+19,794
+16% +$345K 0.29% 45
2016
Q4 		$2.24M Sell
125,050
-12,964
-9% -$235K 0.28% 50
2016
Q3 		$2.87M Sell
138,014
-7,658
-5% -$190K 0.38% 43
2016
Q2 		$3.92M Buy
145,672
+5,336
+4% +$146K 0.54% 36
2016
Q1 		$3.8M Buy
140,336
+8,480
+6% +$227K 0.55% 34
2015
Q4 		$3.83M Buy
131,856
+624
+0.5% +$17.3K 0.56% 35
2015
Q3 		$3.56M Buy
131,232
+1,700
+1% +$48.1K 0.53% 36
2015
Q2 		$3.55M Buy
129,532
+2,728
+2% +$76.7K 0.5% 38
2015
Q1 		$3.38M Sell
126,804
-2,006
-2% -$46.2K 0.48% 40
2014
Q4 		$2.73M Sell
128,810
-740
-0.6% -$16.5K 0.41% 41
2014
Q3 		$3.08M Buy
129,550
+2,800
+2% +$64.4K 0.49% 37
2014
Q2 		$2.93M Buy
126,750
+1,776
+1% +$39.2K 0.47% 38
2014
Q1 		$2.85M Buy
124,974
+1,874
+2% +$39.9K 0.52% 39
2013
Q4 		$2.27M Sell
123,100
-250
-0.2% -$4.36K 0.44% 41
2013
Q3 		$2.09M Buy
123,350
+1,400
+1% +$23.5K 0.44% 43
2013
Q2 		$1.89M Buy
+121,950
New +$2.03M 0.43% 44

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Donaldson Capital Management's NVO Position: Q1 2026 in Review

Donaldson Capital Management reduced its Novo Nordisk (NVO) stake by 2.4% in Q1 2026, selling an estimated $17.8K and leaving 15,418 shares worth $567K. The position accounts for 0.02% of the portfolio, ranked #170.

Donaldson Capital Management first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.69M in Q4 2017. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Donaldson Capital Management held 15,418 shares of Novo Nordisk worth $567K as of Q1 2026.
  • Donaldson Capital Management sold 376 Novo Nordisk shares in Q1 2026, an estimated $17.8K.
  • Novo Nordisk made up 0.02% of Donaldson Capital Management's portfolio in Q1 2026, its #170 holding.
  • Donaldson Capital Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Donaldson Capital Management's Novo Nordisk position peaked at $4.69M in Q4 2017.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Donaldson Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.